Valuation (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] |
The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025: March 31, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | | (In thousands) | | Assets: | | | | | | | | | | Securities, at fair value: | | | | | | | | | | Agency RMBS | | $ | — | | | $ | 199,979 | | | $ | 12,347 | | | $ | 212,326 | | | Non-Agency RMBS | | — | | | 176,005 | | | 310,784 | | | 486,789 | | | CMBS | | — | | | 19,097 | | | 9,786 | | | 28,883 | | | CLOs | | — | | | 71,724 | | | 37,367 | | | 109,091 | | | Asset-backed securities, backed by consumer loans | | — | | | — | | | 53,680 | | | 53,680 | | | Other ABS | | — | | | — | | | 114,879 | | | 114,879 | | | Corporate debt securities | | — | | | — | | | 20,005 | | | 20,005 | | | Corporate equity securities | | 460 | | | — | | | 11,516 | | | 11,976 | | | U.S. Treasury securities | | — | | | 99,196 | | | — | | | 99,196 | | | Loans, at fair value: | | | | | | | | | | Residential mortgage loans | | — | | | — | | | 3,748,165 | | | 3,748,165 | | | Commercial mortgage loans | | — | | | — | | | 623,196 | | | 623,196 | | Consumer loans | | — | | | — | | | 135 | | | 135 | | Corporate loans | | — | | | — | | | 31,479 | | | 31,479 | | | Reverse mortgage loans | | — | | | — | | | 12,990,186 | | | 12,990,186 | | | Forward MSR-related investments, at fair value | | | | | | 72,824 | | | 72,824 | | | MSRs, at fair value | | — | | | — | | | 30,192 | | | 30,192 | | | Loan commitments, at fair value | | — | | | — | | | 10,207 | | | 10,207 | | | Investment in unconsolidated entities, at fair value | | — | | | — | | | 349,722 | | | 349,722 | | | Financial derivatives–assets, at fair value: | | | | | | | | | | Credit default swaps on asset-backed indices | | — | | | 2,207 | | | — | | | 2,207 | | | Credit default swaps on corporate bond indices | | — | | | 1,348 | | | — | | | 1,348 | | | Interest rate swaps | | — | | | 135,146 | | | — | | | 135,146 | | | TBAs | | — | | | 4,619 | | | — | | | 4,619 | | | Futures | | 1,534 | | | — | | | — | | | 1,534 | | | Forwards | | — | | | 67 | | | — | | | 67 | | | Total return swaps | | — | | | — | | | 54 | | | 54 | | | Options | | 7,858 | | | — | | | — | | | 7,858 | | | Warrants | | — | | | 1 | | | — | | | 1 | | Total assets | | $ | 9,852 | | | $ | 709,389 | | | $ | 18,426,524 | | | $ | 19,145,765 | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | (continued) | | (In thousands) | | Liabilities: | | | | | | | | | | Securities sold short, at fair value: | | | | | | | | | | Government debt | | $ | — | | | $ | (297,231) | | | $ | — | | | $ | (297,231) | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | Credit default swaps on asset-backed securities | | — | | | — | | | (2) | | | (2) | | | Credit default swaps on corporate bonds | | — | | | (134) | | | — | | | (134) | | | Credit default swaps on corporate bond indices | | — | | | (5,285) | | | — | | | (5,285) | | | Interest rate swaps | | — | | | (36,752) | | | — | | | (36,752) | | | TBAs | | — | | | (1,606) | | | — | | | (1,606) | | | Options | | (2,978) | | | — | | | — | | | (2,978) | | | Futures | | (527) | | | — | | | — | | | (527) | | | Forwards | | — | | | (90) | | | — | | | (90) | | | Loan purchase commitments, at fair value | | — | | | — | | | (6,443) | | | (6,443) | | | Other secured borrowings, at fair value | | — | | | — | | | (3,125,332) | | | (3,125,332) | | | HMBS-related obligations, at fair value | | — | | | — | | | (10,765,668) | | | (10,765,668) | | | Unsecured borrowings, at fair value | | — | | | — | | | (638,644) | | | (638,644) | | Total liabilities | | $ | (3,505) | | | $ | (341,098) | | | $ | (14,536,089) | | | $ | (14,880,692) | |
December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | | (In thousands) | | Assets: | | | | | | | | | | Securities, at fair value: | | | | | | | | | | Agency RMBS | | $ | — | | | $ | 205,789 | | | $ | 12,578 | | | $ | 218,367 | | | Non-Agency RMBS | | — | | | 185,805 | | | 267,747 | | | 453,552 | | | CMBS | | — | | | 13,615 | | | 12,935 | | | 26,550 | | | CLOs | | — | | | 90,775 | | | 34,265 | | | 125,040 | | | Asset-backed securities, backed by consumer loans | | — | | | — | | | 53,087 | | | 53,087 | | | Other ABS | | — | | | — | | | 97,773 | | | 97,773 | | | Corporate debt securities | | — | | | — | | | 15,530 | | | 15,530 | | | Corporate equity securities | | 337 | | | — | | | 11,654 | | | 11,991 | | | U.S. Treasury securities | | — | | | 32,992 | | | — | | | 32,992 | | | Loans, at fair value: | | | | | | | | | | Residential mortgage loans | | — | | | — | | | 3,643,094 | | | 3,643,094 | | | Commercial mortgage loans | | — | | | — | | | 640,712 | | | 640,712 | | Consumer loans | | — | | | — | | | 159 | | | 159 | | Corporate loans | | — | | | — | | | 25,366 | | | 25,366 | | | Reverse mortgage loans | | — | | | — | | | 12,331,316 | | | 12,331,316 | | | Forward MSR-related investments, at fair value | | | | | | 77,852 | | | 77,852 | | | MSRs, at fair value | | — | | | — | | | 28,913 | | | 28,913 | | | Loan commitments, at fair value | | — | | | — | | | 9,124 | | | 9,124 | | | Investment in unconsolidated entities, at fair value | | — | | | — | | | 312,421 | | | 312,421 | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | (continued) | | (In thousands) | | Financial derivatives–assets, at fair value: | | | | | | | | | | Credit default swaps on asset-backed indices | | — | | | 2,206 | | | — | | | 2,206 | | | Credit default swaps on corporate bond indices | | — | | | 4,621 | | | — | | | 4,621 | | | Interest rate swaps | | — | | | 128,898 | | | — | | | 128,898 | | | TBAs | | — | | | 257 | | | — | | | 257 | | | Futures | | 1,095 | | | — | | | — | | | 1,095 | | | Forwards | | — | | | 14 | | | — | | | 14 | | | Total return swaps | | — | | | — | | | 24 | | | 24 | | | Options | | 5,607 | | | — | | | — | | | 5,607 | | | Warrants | | — | | | 1 | | | — | | | 1 | | Total assets | | $ | 7,039 | | | $ | 664,973 | | | $ | 17,574,550 | | | $ | 18,246,562 | | | | | | | | | | | | | | | | | | | | | | | | Liabilities: | | | | | | | | | | Securities sold short, at fair value: | | | | | | | | | Government debt | | $ | — | | | $ | (272,702) | | | $ | — | | | $ | (272,702) | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | Credit default swaps on asset-backed securities | | — | | | — | | | (2) | | | (2) | | | Credit default swaps on corporate bonds | | — | | | (155) | | | — | | | (155) | | | Credit default swaps on corporate bond indices | | — | | | (25,407) | | | — | | | (25,407) | | | Interest rate swaps | | — | | | (26,797) | | | — | | | (26,797) | | | TBAs | | — | | | (598) | | | — | | | (598) | | | Futures | | (45) | | | — | | | — | | | (45) | | | Forwards | | — | | | (69) | | | — | | | (69) | | | Loan purchase commitments, at fair value | | — | | | — | | | (42) | | | (42) | | Other secured borrowings, at fair value | | — | | | — | | | (2,945,578) | | | (2,945,578) | | | HMBS-related obligations, at fair value | | — | | | — | | | (10,406,332) | | | (10,406,332) | | | Unsecured borrowings, at fair value | | — | | | — | | | (659,832) | | | (659,832) | | Total liabilities | | $ | (45) | | | $ | (325,728) | | | $ | (14,011,786) | | | $ | (14,337,559) | |
|
| Schedule of Significant Unobservable Inputs, Qualitative Information |
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of March 31, 2026: March 31, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | | Description | | | | | Min | | Max | | | | (In thousands) | | | | | | | | | | | Non-Agency RMBS | | $ | 140,765 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.45 | | | $ | 179.88 | | | $ | 31.97 | | | | 170,019 | | | Discounted Cash Flows | | | | | | | | | | | 310,784 | | | | | Yield | | 1.1 | % | | 86.8 | % | | 16.7 | % | | | | | | | Projected Collateral Prepayments | | 0.0 | % | | 100.0 | % | | 82.5 | % | | | | | | | Projected Collateral Losses | | 0.0 | % | | 57.5 | % | | 4.4 | % | | | | | | | Projected Collateral Recoveries | | 0.0 | % | | 49.5 | % | | 3.5 | % | | Non-Agency CMBS | | 7,754 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 5.64 | | | $ | 77.66 | | | $ | 41.18 | | | | 2,032 | | | Discounted Cash Flows | | | | | | | | | | | 9,786 | | | | | Yield | | 10.4 | % | | 26.3 | % | | 17.9 | % | | | | | | | Projected Collateral Losses | | 0.0 | % | | 93.0 | % | | 12.0 | % | | | | | | | Projected Collateral Recoveries | | 7.0 | % | | 100.0 | % | | 87.5 | % | CLOs | | 15,630 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 10.61 | | | $ | 97.24 | | | $ | 56.86 | | | | 21,737 | | | Discounted Cash Flows | | | | | | | | | | | 37,367 | | | | | Yield | | 3.7 | % | | 65.4 | % | | 17.0 | % | Agency interest only RMBS | | 6,296 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 1.19 | | | $ | 18.99 | | | $ | 8.13 | | | | 6,051 | | | Option Adjusted Spread ("OAS") | | | | | | | | | | | 12,347 | | | | | SOFR OAS(1) | | 16 | | | 3,258 | | | 548 | | | | | | | | Projected Collateral Prepayments | | 16.2 | % | | 96.5 | % | | 55.4 | % | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ABS | | 95,131 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 2.20 | | | $ | 100.12 | | | $ | 69.10 | | | | 73,428 | | | Discounted Cash Flows | | | | | | | | | | | 168,559 | | | | | Yield | | 2.7 | % | | 37.3 | % | | 11.7 | % | | | | | | | Projected Collateral Prepayments | | 0.0 | % | | 57.8 | % | | 16.8 | % | | | | | | | Projected Collateral Losses | | 0.0 | % | | 34.4 | % | | 19.3 | % | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate debt and equity | | 31,521 | | | Discounted Cash Flows | | Yield | | 0.1 | % | | 59.2 | % | | 18.0 | % | Performing and re-performing residential mortgage loans | | 1,977,901 | | | Discounted Cash Flows | | Yield | | 0.2 | % | | 24.4 | % | | 6.6 | % | Securitized residential mortgage loans(2)(3) | | 1,550,394 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.50 | | | $ | 100.00 | | | $ | 90.99 | | | | 68,970 | | | Discounted Cash Flows | | | | | | | | | | | 1,619,364 | | | | | Yield | | — | % | | 26.7 | % | | 6.4 | % | Non-performing residential mortgage loans | | 150,900 | | | Discounted Cash Flows | | Yield | | 0.4 | % | | 110.2 | % | | 7.6 | % | | | | | | | Recovery Amount | | 0.5 | % | | 257.2 | % | | 87.8 | % | | | | | | | Months to Resolution/Maturity | | 3.2 | | | 107.1 | | | 21.1 | | | Performing commercial mortgage loans | | 588,028 | | | Discounted Cash Flows | | Yield | | 7.0 | % | | 10.6 | % | | 8.7 | % | Non-performing commercial mortgage loans | | 35,168 | | | Discounted Cash Flows | | Yield | | 8.5 | % | | 13.3 | % | | 9.5 | % | | | | | | | Recovery Amount | | 80.0 | % | | 100.0 | % | | 98.8 | % | | | | | | | Months to Resolution | | 1.0 | | 12.0 | | 5.8 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | | Description | | | | | Min | | Max | | | (continued) | | (In thousands) | | | | | | | | | | | Consumer loans | | 135 | | | Discounted Cash Flows | | Yield | | 12.0 | % | | 12.2 | % | | 12.0 | % | | | | | | | Projected Collateral Prepayments | | — | % | | 30.2 | % | | 9.6 | % | | | | | | | Projected Collateral Losses | | 0.6 | % | | 82.3 | % | | 21.7 | % | Corporate loans | | 31,479 | | | Discounted Cash Flows | | Yield | | — | % | | 26.0 | % | | 13.9 | % | | Reverse Mortgage Loans—HECM | | 11,015,347 | | | Discounted Cash Flows | | Yield | | 2.8 | % | | 6.3 | % | | 4.2 | % | | | | | | | Conditional Prepayment Rate | | 1.7 | % | | 39.3 | % | | 7.7 | % | | Reverse Mortgage Loans—HECM buyouts | | 41,526 | | | Discounted Cash Flows | | Yield | | 5.2 | % | | 11.4 | % | | 8.5 | % | | | | | | | Months to Resolution | | 1.0 | | 153.7 | | 21.2 | | Reverse Mortgage Loans—Unsecuritized Proprietary | | 299,745 | | | Discounted Cash Flows | | Yield | | 5.8 | % | | 10.0 | % | | 7.1 | % | | | | | | | Conditional Prepayment Rate | | 6.9 | % | | 55.5 | % | | 12.8 | % | Reverse Mortgage Loans—Securitized Proprietary(2) | | 1,633,568 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 89.94 | | | $ | 113.27 | | | $ | 108.01 | | | | | | | | Yield | | 5.0 | % | | 7.9 | % | | 5.5 | % | | Forward MSR-related investments | | 72,824 | | | Discounted Cash Flows | | Yield | | 9.5 | % | | 9.5 | % | | 9.5 | % | | | | | | | Conditional Prepayment Rate | | 5.0 | % | | 5.0 | % | | 5.0 | % | | MSRs | | 30,192 | | | Discounted Cash Flows | | Yield | | 17.4 | % | | 17.4 | % | | 17.4 | % | | | | | | | Conditional Prepayment Rate | | 10.3 | % | | 42.6 | % | | 14.6 | % | | Loan Commitments | | 10,207 | | | Discounted Cash Flows | | Pull-through rate | | 66.0 | % | | 94.5 | % | | 69.5 | % | | | | | | | Cost to originate | | 3.8 | % | | 10.8 | % | | 5.4 | % | | Investment in unconsolidated entities—Loan origination and mortgage-related entities | | 82,960 | | | Enterprise Value | | Equity Price-to-Book(4) | | 0.4x | | 2.6x | | 2.3x | | Investment in unconsolidated entities—Other | | 266,762 | | | Enterprise Value | | Net Asset Value | | n/a | | n/a | | n/a | | | 349,722 | | | | | | | | | | | | | Loan Purchase Commitments | | (6,443) | | | Transaction Price | | Yield | | 5.6 | % | | 7.0 | % | | 6.1 | % | | Total return swaps | | 54 | | | Discounted Cash Flows | | Yield | | 22.7 | % | | 22.7 | % | | 22.7 | % | | Credit default swaps on asset-backed securities | | (2) | | | Net Discounted Cash Flows | | Projected Collateral Prepayments | | 22.9 | % | | 22.9 | % | | 22.9 | % | | | | | | | Projected Collateral Losses | | 8.6 | % | | 8.6 | % | | 8.6 | % | | | | | | | Projected Collateral Recoveries | | 12.3 | % | | 12.3 | % | | 12.3 | % | Other secured borrowings, at fair value(2) | | (3,125,332) | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.50 | | | $ | 100.00 | | | $ | 93.00 | | | | | | | | Yield | | 4.5% | | 59.1% | | 5.6% | | | | | | | Projected Collateral Prepayments | | 1.9% | | 77.6% | | 49.6% | | HMBS-related obligations, at fair value | | (10,765,668) | | | Discounted Cash Flows | | Yield | | 2.6% | | 6.1% | | 4.0% | | | | | | | Conditional Prepayment Rate | | 6.9% | | 39.3% | | 7.6% | | Unsecured borrowings, at fair value | | (638,644) | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 81.50 | | | $ | 99.10 | | | $ | 96.40 | |
(1)Shown in basis points. (2)Securitized residential mortgage loans, Reverse Mortgage Loans—Securitized Proprietary, and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2. (3)Includes $61.9 million of non-performing securitized residential mortgage loans. (4)Represents an estimation of where market participants might value an enterprise on a price-to-book basis. For the range minimum, the range maximum, and the weighted average price-to-book ratio, excludes investments in unconsolidated entities with a total fair value of $0.6 million. Including such investments, the weighted average price-to-book ratio was 2.3x
|
| Fair Value Measurement Using Significant Unobservable Inputs |
The tables below include roll-forwards of the Company's financial instruments for the three-month periods ended March 31, 2026 and 2025 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Three-Month Period Ended March 31, 2026 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of December 31, 2025 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/Payments(1) | | Sales/ Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of March 31, 2026 | | Assets: | | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 12,578 | | | $ | (617) | | | $ | 629 | | | $ | (710) | | | $ | 6,089 | | | $ | (6,171) | | | $ | 549 | | | $ | — | | | $ | 12,347 | | | Non-Agency RMBS | 267,747 | | | (19,364) | | | 2,889 | | | (2,513) | | | 101,608 | | | (35,148) | | | 10,946 | | | (15,381) | | | 310,784 | | | CMBS | 12,935 | | | 26 | | | — | | | (651) | | | — | | | — | | | — | | | (2,524) | | | 9,786 | | | CLOs | 34,265 | | | (203) | | | (435) | | | (3,913) | | | 4,089 | | | (1,575) | | | 5,906 | | | (767) | | | 37,367 | | | Asset-backed securities backed by consumer loans | 53,087 | | | (1,833) | | | (2,572) | | | 2,452 | | | 7,451 | | | (4,905) | | | — | | | — | | | 53,680 | | | Other ABS | 97,773 | | | (2,543) | | | (188) | | | 45 | | | 31,930 | | | (12,138) | | | — | | | — | | | 114,879 | | | Corporate debt securities | 15,530 | | | — | | | (235) | | | (179) | | | 7,691 | | | (2,802) | | | — | | | — | | | 20,005 | | | Corporate equity securities | 11,654 | | | — | | | 3 | | | (177) | | | 41 | | | (5) | | | — | | | — | | | 11,516 | | | Loans, at fair value: | | | | | | | | | | | | | | | | | | | Residential mortgage loans | 3,643,094 | | | 835 | | | 14,159 | | | (21,358) | | | 1,857,344 | | | (1,745,909) | | | — | | | — | | | 3,748,165 | | | Commercial mortgage loans | 640,712 | | | 256 | | | 520 | | | 372 | | | 183,147 | | | (201,811) | | | — | | | — | | | 623,196 | | | Consumer loans | 159 | | | (18) | | | (20) | | | 32 | | | 10 | | | (28) | | | — | | | — | | | 135 | | | Corporate loans | 25,366 | | | — | | | — | | | (158) | | | 10,496 | | | (4,225) | | | — | | | — | | | 31,479 | | Reverse mortgage loans(3) | 12,331,316 | | | (266) | | | (16) | | | 248,307 | | | 656,242 | | | (245,397) | | | — | | | — | | | 12,990,186 | | | Forward MSR-related investments, at fair value | 77,852 | | | 2,743 | | | — | | | (482) | | | — | | | (7,289) | | | — | | | — | | | 72,824 | | MSRs, at fair value(3) | 28,913 | | | — | | | — | | | 1,279 | | | — | | | — | | | — | | | — | | | 30,192 | | | Loan commitments, at fair value | 9,124 | | | — | | | — | | | 1,083 | | | — | | | — | | | — | | | — | | | 10,207 | | | Investments in unconsolidated entities, at fair value | 312,421 | | | — | | | 5,100 | | | 12,464 | | | 176,783 | | | (157,046) | | | — | | | — | | | 349,722 | | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | | Total return swaps | 24 | | | — | | | 7 | | | 30 | | | 47 | | | (54) | | | — | | | — | | | 54 | | | Total assets, at fair value | $ | 17,574,550 | | | $ | (20,984) | | | $ | 19,841 | | | $ | 235,923 | | | $ | 3,042,968 | | | $ | (2,424,503) | | | $ | 17,401 | | | $ | (18,672) | | | $ | 18,426,524 | | | Liabilities: | | | | | | | | | | | | | | | | | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | | | | | | | | | | Total return swaps | $ | — | | | $ | — | | | $ | (47) | | | $ | — | | | $ | 48 | | | $ | (1) | | | $ | — | | | $ | — | | | $ | — | | | Credit default swaps on asset-backed securities | (2) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (2) | | | Loan purchase commitments, at fair value | (42) | | | — | | | — | | | (6,401) | | | — | | | — | | | — | | | — | | | (6,443) | | | Other secured borrowings, at fair value | (2,945,578) | | | (3,406) | | | — | | | 8,823 | | | 62,305 | | | (247,476) | | | — | | | — | | | (3,125,332) | | | Unsecured borrowings, at fair value | (659,832) | | | — | | | — | | | 21,188 | | | — | | | — | | | — | | | — | | | (638,644) | | HMBS-related obligations, at fair value(3) | (10,406,332) | | | — | | | — | | | (194,107) | | | 228,649 | | | (393,878) | | | — | | | — | | | (10,765,668) | | | Total liabilities, at fair value | $ | (14,011,786) | | | $ | (3,406) | | | $ | (47) | | | $ | (170,497) | | | $ | 291,002 | | | $ | (641,355) | | | $ | — | | | $ | — | | | $ | (14,536,089) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value and Forward MSR-related investments, at fair value, amount represents distributions received. (3)Change in net unrealized gain (loss) represents the net change in fair value which can include interest income, interest expense, and realized and unrealized gains and losses. Three-Month Period Ended March 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of December 31, 2024 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/Payments(1) | | Sales/Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of March 31, 2025 | | Assets: | | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 10,660 | | | $ | (368) | | | $ | 38 | | | $ | 355 | | | $ | 753 | | | $ | (848) | | | $ | 655 | | | $ | (492) | | | $ | 10,753 | | | Non-Agency RMBS | 153,188 | | | (7,022) | | | 406 | | | (633) | | | 74,919 | | | (10,903) | | | 6,957 | | | (25,438) | | | 191,474 | | | CMBS | 21,399 | | | 306 | | | 516 | | | (1,116) | | | — | | | (3,050) | | | 5,302 | | | (5,670) | | | 17,687 | | | CLOs | 22,678 | | | (1,413) | | | 83 | | | (1,175) | | | 623 | | | (8,680) | | | — | | | — | | | 12,116 | | | Asset-backed securities backed by consumer loans | 60,227 | | | (1,714) | | | (2,008) | | | (667) | | | 6,857 | | | (6,347) | | | — | | | — | | | 56,348 | | | Other ABS | 35,483 | | | 132 | | | 1,070 | | | (1,127) | | | 1,020 | | | (12,097) | | | — | | | — | | | 24,481 | | | Corporate debt securities | 14,352 | | | — | | | 382 | | | (513) | | | 3,344 | | | (4,177) | | | — | | | — | | | 13,388 | | | Corporate equity securities | 9,759 | | | — | | | 636 | | | 68 | | | 493 | | | (1,646) | | | — | | | — | | | 9,310 | | | Loans, at fair value: | | | | | | | | | | | | | | | | | | | Residential mortgage loans | 3,539,534 | | | 2,316 | | | (2,459) | | | 23,797 | | | 917,705 | | | (1,155,729) | | | — | | | — | | | 3,325,164 | | | Commercial mortgage loans | 350,515 | | | 45 | | | (10,075) | | | 11,717 | | | 58,746 | | | (54,770) | | | — | | | — | | | 356,178 | | | Consumer loans | 477 | | | (35) | | | 25 | | | (22) | | | 14 | | | (89) | | | — | | | — | | | 370 | | | Corporate loans | 11,767 | | | — | | | — | | | 115 | | | 22,200 | | | (22,965) | | | — | | | — | | | 11,117 | | Reverse mortgage loans(3) | 10,097,279 | | | — | | | — | | | 196,378 | | | 464,479 | | | (176,807) | | | — | | | — | | | 10,581,329 | | | Forward MSR-related investments, at fair value | 77,848 | | | 2,654 | | | — | | | 14,748 | | | — | | | (8,047) | | | — | | | — | | | 87,203 | | MSRs, at fair value(3) | 29,766 | | | — | | | — | | | (230) | | | — | | | — | | | — | | | — | | | 29,536 | | | Loan commitments, at fair value | 6,692 | | | — | | | — | | | 523 | | | — | | | — | | | — | | | — | | | 7,215 | | | Loan purchase commitments, at fair value | — | | | — | | | — | | | 1,342 | | | — | | | — | | | — | | | — | | | 1,342 | | | Investments in unconsolidated entities, at fair value | 220,078 | | | — | | | (5,068) | | | 13,372 | | | 128,768 | | | (88,057) | | | — | | | — | | | 269,093 | | | Total assets, at fair value | $ | 14,661,702 | | | $ | (5,099) | | | $ | (16,454) | | | $ | 256,932 | | | $ | 1,679,921 | | | $ | (1,554,212) | | | $ | 12,914 | | | $ | (31,600) | | | $ | 15,004,104 | | | Liabilities: | | | | | | | | | | | | | | | | | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | | | | | | | | | | Credit default swaps on asset-backed securities | $ | (3) | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | (3) | | | Loan purchase commitments, at fair value | (1,602) | | | — | | | — | | | 1,602 | | | — | | | — | | | — | | | — | | | — | | | Other secured borrowings, at fair value | (1,934,309) | | | (1,458) | | | — | | | (30,559) | | | 39,615 | | | — | | | — | | | — | | | (1,926,711) | | | Unsecured borrowings, at fair value | (281,912) | | | — | | | (1,383) | | | 1,027 | | | 34,931 | | | — | | | — | | | — | | | (247,337) | | | HMBS-related obligations, at fair value | (9,150,883) | | | — | | | — | | | (147,470) | | | 186,723 | | | (383,502) | | | — | | | — | | | (9,495,132) | | | Total liabilities, at fair value | $ | (11,368,709) | | | $ | (1,458) | | | $ | (1,383) | | | $ | (175,400) | | | $ | 261,269 | | | $ | (383,502) | | | $ | — | | | $ | — | | | $ | (11,669,183) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value, amount represents distributions received. (3)Change in net unrealized gain (loss) represents the net change in fair value which can include interest income and realized and unrealized gains and losses.
|
| Schedule of Financial Instruments |
The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | (In thousands) | | Fair Value | | Carrying Value | | Fair Value | | Carrying Value | | Other financial instruments | | | | | | | | | | Assets: | | | | | | | | | | Cash and cash equivalents | | $ | 163,224 | | | $ | 163,224 | | | $ | 201,893 | | | $ | 201,893 | | | Restricted cash | | 28,296 | | | 28,296 | | | 136,297 | | | 136,297 | | | Due from brokers | | 39,708 | | | 39,708 | | | 35,919 | | | 35,919 | | | Reverse repurchase agreements | | 487,333 | | | 487,333 | | | 453,037 | | | 453,037 | | | Liabilities: | | | | | | | | | | Repurchase agreements | | 2,894,972 | | | 2,894,972 | | | 2,655,444 | | | 2,655,444 | | | Other secured borrowings | | 264,444 | | | 264,444 | | | 296,398 | | | 296,398 | | | Due to brokers | | 65,024 | | | 65,024 | | | 48,104 | | | 48,104 | |
Cash and cash equivalents generally includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and investments which are liquid in nature, such as investments in money market accounts or U.S. Treasury Bills, for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in segregated accounts for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature.
|
| Schedule of change in unrealized gain/(loss) on Level 3 Assets and Liabilities still held and outstanding |
The following table details the change in net unrealized gain (loss) for Level 3 financial instruments still held by the Company at March 31, 2026. | | | | | | | | | | (In thousands) | | Three-Month Period Ended March 31, 2026 | | Securities, at fair value | | $ | (6,584) | | | Loans, at fair value | | 222,098 | | | Forward MSR-related investments, at fair value | | (482) | | | MSRs, at fair value | | 1,279 | | | Loan purchase commitments, at fair value | | (6,419) | | | Loan commitments, at fair value | | 9,623 | | Investments in unconsolidated entities, at fair value | | 12,743 | | | Financial derivatives-assets, at fair value | | 30 | | Other secured borrowings, at fair value | | 8,823 | | Unsecured borrowings, at fair value | | 21,188 | | HMBS-related obligations, at fair value | | (194,107) | |
The following table details the change in net unrealized gain (loss) for Level 3 financial instruments still held by the Company at March 31, 2025. | | | | | | | | | | (In thousands) | | Three-Month Period Ended March 31, 2025 | | Securities, at fair value | | $ | (3,514) | | | Loans, at fair value | | 211,522 | | | Forward MSR-related investments, at fair value | | 14,748 | | | MSRs, at fair value | | (230) | | | Loan purchase commitments, at fair value | | 1,342 | | | Loan commitments, at fair value | | 6,540 | | Investments in unconsolidated entities, at fair value | | 4,093 | | Other secured borrowings, at fair value | | (30,559) | | Unsecured borrowings, at fair value | | (127) | | HMBS-related obligations, at fair value | | (147,470) | |
|